49 research outputs found
Barrett's oesophagus: Epidemiology, cancer risk and implications for management
Although endoscopic surveillance of patients with Barrett's oesophagus has been widely implemented, its effectiveness is debateable. The recently reported low annual oesophageal adenocarcinoma risk in population studies, the failure to identify most Barrett's patients at risk of disease progression, the poor adherence to surveillance and biopsy protocols, and the significant risk of misclassification of dysplasia all tend to undermine the effectiveness of current management, in particular, endoscopic surveillance programmes, to prevent or improve the outcomes of patients with oesophageal adenocarcinoma. The ongoing increase in incidence of Barrett's oesophagus and consequent growth of the surveillance population, together with the associated discomfort and costs of endoscopic surveillance, demand improved techniques for accurately determining individual risk of oesophageal adenocarcinoma. More accurate techniques are needed to run efficient surveillance programmes in the coming decades. In this review, we will discuss the current knowledge on the epidemiology of Barrett's oesophagus, and the challenging epidemiological dilemmas that need to be addressed when a
Generalized Farey trees, transfer Operators and phase transitions
We consider a family of Markov maps on the unit interval, interpolating
between the tent map and the Farey map. The latter map is not uniformly
expanding. Each map being composed of two fractional linear transformations,
the family generalizes many particular properties which for the case of the
Farey map have been successfully exploited in number theory. We analyze the
dynamics through the spectral analysis of generalized transfer operators.
Application of the thermodynamic formalism to the family reveals first and
second order phase transitions and unusual properties like positivity of the
interaction function.Comment: 39 pages, 10 figure
Colorectal cancer
Surgical oncolog
Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer
10.1038/ncomms5988Nature Communications5498